De-differentiated Chondrosarcoma
CIM Case: De-differentiated Chondrosarcoma
Clinical Scenario
Patient: 62-year-old retired engineer Presentation: 3-month history of progressive right hip and groin pain following a minor fall, now requiring walking stick, night pain disturbing sleep Relevant history: Known enchondroma in proximal right femur monitored with X-rays for 10 years (stable until now), no previous surgery, no other medical conditions, non-smoker, independent mobility prior to current symptoms Examination findings:
- Slim man, looks well but uncomfortable
- Antalgic gait, using single-point stick
- Palpable fullness over anterolateral right proximal thigh
- Firm mass, fixed to deep structures
- No overlying skin changes
- Tenderness over greater trochanter region
- Hip ROM: flexion 90° (limited by pain), internal rotation 10° (limited), external rotation 20°
- No lymphadenopathy (inguinal)
- Neurovascularly intact distally
- No stigmata of Ollier disease or Maffucci syndrome
Investigations Provided
Laboratory Results
| Test | Result | Normal Range | Interpretation |
|---|---|---|---|
| Hb | 128 g/L | 130-170 g/L | ↓ Mildly low |
| WCC | 8.2 ×10⁹/L | 4-11 ×10⁹/L | Normal |
| Platelets | 285 ×10⁹/L | 150-400 ×10⁹/L | Normal |
| CRP | 15 mg/L | <5 mg/L | ↑ Mildly elevated |
| ESR | 28 mm/hr | <20 mm/hr | ↑ Elevated |
| ALP | 165 U/L | 30-120 U/L | ↑ Elevated |
| LDH | 310 U/L | 120-250 U/L | ↑ Elevated |
| Calcium | 2.45 mmol/L | 2.2-2.6 mmol/L | Normal |
| Albumin | 38 g/L | 35-50 g/L | Normal |
| Creatinine | 95 μmol/L | 60-110 μmol/L | Normal |
Imaging
Image 1: AP and Lateral Radiographs of Right Hip/Proximal Femur
Radiological features:
- Large destructive lesion in proximal femur (intertrochanteric region)
- Biphasic appearance: areas of chondroid matrix (rings and arcs) AND areas of aggressive osteolysis
- Cortical destruction with breakthrough
- Periosteal reaction (Codman triangle, sunburst pattern)
- Soft tissue mass extending medially and laterally
- No pathological fracture yet but high risk
- Size approximately 10 x 8cm
- Extends from lesser trochanter to subtrochanteric region
Image 2: MRI of Right Proximal Femur
Findings:
- Large heterogeneous mass in proximal femur
- Bimorphic pattern: high T2 signal lobulated component (cartilage) adjacent to aggressive solid component
- Abrupt transition between components (diagnostic feature)
- Extensive medullary involvement
- Cortical destruction with extra-osseous extension
- Soft tissue mass 6cm in maximum dimension
- No skip lesions
- Neurovascular bundle displaced but appears intact
- Edema in adjacent muscles
Image 3: CT Chest (Staging)
Findings:
- Two pulmonary nodules (right lower lobe 8mm, left lower lobe 5mm)
- Suspicious for pulmonary metastases
- No mediastinal lymphadenopathy
- No pleural effusion
Questions & Model Answers
What is the diagnosis and differential diagnosis?
What is the epidemiology and pathophysiology of this tumour?
What staging investigations would you perform?
How would you manage this patient?
What are the prognostic factors and expected outcomes?
What surveillance is appropriate for patients with enchondromas?
Key Teaching Points
Pattern Recognition
This pattern suggests Dedifferentiated Chondrosarcoma:
- Elderly patient with longstanding cartilage lesion
- New aggressive symptoms (night pain, rapid progression)
- Biphasic radiological appearance
- Abrupt transition between low-grade and high-grade components on imaging/histology
- Elevated ALP and LDH
Distinguish from Conventional Chondrosarcoma:
| Feature | Conventional | Dedifferentiated |
|---|---|---|
| Appearance | Uniform cartilage pattern | Biphasic (two distinct components) |
| Transition | Gradual grade variation | Abrupt transition |
| Prognosis | Grade-dependent (30-90%) | Uniformly poor (7-18%) |
| Chemo response | None | May respond (high-grade component) |
| Behaviour | Primarily local | Early metastases |
Critical Management Points
- Recognise biphasic pattern - key to diagnosis
- Biopsy BOTH components - sampling error can miss diagnosis
- Stage completely - high rate of metastases at presentation
- MDT discussion essential - complex decision-making
- Discuss prognosis honestly - poor survival, palliative care involvement
- Surgical resection if feasible - even in metastatic disease for palliation
- Chemotherapy role limited - may benefit high-grade component
Common Examiner Follow-ups
Q: "What is the difference between dedifferentiated and high-grade conventional chondrosarcoma?"
| Feature | Dedifferentiated | Conventional Grade III |
|---|---|---|
| Pattern | Biphasic (two distinct components) | Uniform high-grade cartilage |
| Matrix | Absent in high-grade component | Cartilage matrix present |
| Chemo sensitivity | Partial (high-grade component) | Chemoresistant |
| Prognosis | 7-18% 5-year | 30-50% 5-year |
| Transition | Abrupt | Not applicable |
The key distinction is the abrupt transition between recognisable low-grade cartilage and high-grade non-cartilaginous sarcoma.
Q: "Would you offer chemotherapy to this patient?"
Chemotherapy considerations:
Arguments for:
- Metastatic disease - some treatment better than none
- High-grade component may respond (osteosarcoma-like or MFH-like)
- 20-30% response rate reported
Arguments against:
- Overall survival benefit unproven
- Significant toxicity
- Limited performance status impact
- Resources for likely palliative outcome
Decision: Discuss with patient, offer if good performance status and willing. Consider doxorubicin-based regimen. Realistic expectation is disease stabilisation rather than cure.
Q: "The patient asks about survival. How do you counsel them?"
Approach to prognostic discussion:
- Assess patient's understanding and wishes - "What do you understand about your condition?"
- Provide honest information - "This is a serious condition with limited treatment options"
- Frame realistically - "Survival is typically measured in months rather than years"
- Focus on goals - "What's most important to you right now?"
- Emphasise quality of life - "We can control pain and maintain your independence"
- Introduce palliative care - "Our palliative care team helps with symptom control"
- Leave hope without false promises - "Everyone is different, but we need to plan realistically"
Key message: Honest but compassionate communication, focus on achievable goals.
Q: "What reconstruction would you use for proximal femoral resection?"
| Option | Advantages | Disadvantages |
|---|---|---|
| Proximal femoral replacement (megaprosthesis) | Immediate stability, early weight-bearing, predictable | Infection risk, dislocation, implant complications |
| Allograft-prosthetic composite | Bone stock restoration, soft tissue attachment | Nonunion, fracture, longer rehab |
| Intercalary allograft | Biological reconstruction | High complication rate |
| Arthrodesis | Durable if united | Loss of motion, difficult surgery |
For this patient with metastatic disease and limited prognosis: Megaprosthesis - provides rapid rehabilitation and function for remaining life.
Related Topics
- Conventional Chondrosarcoma
- Enchondroma
- Ollier Disease and Maffucci Syndrome
- Proximal Femoral Replacement
- Bone Metastases Management
- Osteosarcoma
- Bone Sarcoma Staging